Atara Biotherapeutics, Inc. (ATRA)

NASDAQ: ATRA · Real-Time Price · USD

9.73

+0.27 (2.85%)

Aug 25, 2026, 1:57 PM EDT - Market open

Atara Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	98	130	77	52	311	1,393
Market Cap Growth	12.65%	70.14%	46.68%	-83.20%	-77.67%	-14.29%
Enterprise Value	98	134	59	12	122	1,061
Last Close Price	9.46	18.09	13.31	12.82	82.00	394.00

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	3.99	-	-	-	-
Forward PE	65.97	19.66	0.30	-	-	-
PS Ratio	15.33	1.08	0.60	6.10	4.89	68.51
PB Ratio	-	-3.39	-0.79	-0.53	2.46	4.98
P/TBV Ratio	-	-	-	-	2.46	4.98

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	15.33	1.11	0.46	1.36	1.93	52.15
EV/EBITDA Ratio	-	2.59	-	-	-	-
EV/EBIT Ratio	-	2.70	-	-	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-0.27	-0.27	-0.45	-0.58	0.57	0.10
Debt / EBITDA Ratio	-	0.18	-	-	-	-
Net Debt / Equity Ratio	0	-0.05	-0.01	-0.06	-1.35	-1.23
Net Debt / EBITDA Ratio	0.00	0.04	-0.02	-0.02	0.64	1.03
Net Debt / FCF Ratio	0	-0.04	-0.02	-0.03	0.62	1.48
Asset Turnover	0.21	1.87	0.94	0.03	0.15	0.04
Inventory Turnover	-	-	15.25	40.39	-	-
Quick Ratio	1.49	0.65	0.33	0.60	3.60	3.53
Current Ratio	1.98	0.82	0.48	0.72	3.74	3.64
Return on Equity (ROE)	-	-	-	-2014.86%	-112.39%	-91.69%
Return on Assets (ROA)	-24.14%	47.81%	-35.66%	-62.11%	-40.63%	-40.29%
Return on Capital Employed (ROCE)	-78.90%	931.10%	307.50%	-1156.80%	-92.30%	-94.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-17.57%	25.06%	-111.40%	-528.31%	-73.36%	-24.41%
FCF Yield	-23.06%	-39.05%	-89.96%	-371.56%	-88.25%	-16.59%
Buyback Yield / Dilution	-36.26%	-69.84%	-76.77%	-3.83%	-8.88%	-26.63%

SEC Filings: 10-K · 10-Q